Holen Sie sich die Stockscreener-App
53.97
3.62%
-2.03
Handel nachbörslich:
54.00
0.03
+0.06%
Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
17.28%
240.34
|
204.92 | 192.57 | 161.71 | 141.15 |
| Cost Of Revenue |
22.93%
41.19
|
33.51 | 38.14 | 28.09 | 18.94 |
Selling, General, and Administrative
|
6.90%
82.13
|
88.22 | - | - | - |
| Costs And Expenses |
28.53%
218.66
|
170.12 | 142.08 | 132.34 | 106.31 |
| Operating Income/Loss |
37.71%
21.67
|
34.80 | 50.49 | 29.36 | 34.84 |
| Nonoperating Income/Loss |
20.73%
-11.44
|
-14.43 | -5.401 | -3.456 | -3.923 |
| Income/Loss From Continuing Operations Before Tax |
49.74%
10.23
|
20.36 | 45.09 | 25.91 | 30.92 |
| Income Tax Expense/Benefit, Deferred |
81.68%
0.708
|
3.864 | 18.63 | - | - |
| Income Tax Expense/Benefit |
318.60%
2.453
|
0.586 | 22.06 | -364.99 | 2.733 |
| Net Income/Loss |
60.66%
7.781
|
19.78 | 23.04 | 390.89 | 28.19 |
| Basic Average Shares |
1.85%
141.77
|
144.44 | -1.9568 | 145.42 | 146.74 |
| Diluted Average Shares |
1.74%
157.28
|
160.06 | -0.6896 | 161.00 | 162.56 |
| Basic Earnings Per Share |
64.29%
0.05
|
0.14 | 0.20 | 2.69 | 0.19 |
| Diluted Earnings Per Share |
58.33%
0.05
|
0.12 | 0.15 | 2.43 | 0.17 |
2.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):